MRKR (STOCKS)
Marker Therapeutics, Inc. Common Stock
$1.740000
-0.010000 (-0.57%)
Prev close: $1.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Juan F. Vera
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $28.68M
- Employees
- 5
- P/E (TTM)
- -1.91
- P/B (TTM)
- 1.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.09 | $-0.20 | +0.1106 | +55.13% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.46 | +0.3390 | +73.86% |
|
Jun 2025 (Q2)
|
$-0.29 | $-0.42 | +0.1282 | +30.66% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.50 | +0.1403 | +28.04% |
Financial Statements
| Revenues | $3.55M |
| Benefits Costs and Expenses | $15.73M |
| Costs And Expenses | $15.73M |
| Operating Expenses | $16.44M |
| Research and Development | $11.80M |
| Other Operating Expenses | $4.64M |
| Operating Income/Loss | -$12.89M |
| Income/Loss From Continuing Operations After Tax | -$12.16M |
| Income/Loss From Continuing Operations Before Tax | -$12.18M |
| Income Tax Expense/Benefit | -$15.16K |
| Net Income/Loss | -$12.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.79 |
| Diluted Earnings Per Share | -$0.79 |
| Basic Average Shares | 15,310,308 |
| Diluted Average Shares | 15,310,308 |
| Assets | $19.07M |
| Current Assets | $19.07M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.27M |
| Current Liabilities | $2.27M |
| Accounts Payable | $793.73K |
| Wages | $87.08K |
| Other Current Liabilities | $1.39M |
| Noncurrent Liabilities | $0.00 |
| Equity | $16.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $16.80M |
| Liabilities And Equity | $19.07M |
| Net Cash Flow From Operating Activities | -$12.01M |
| Net Cash Flow From Operating Activities, Continuing | -$12.01M |
| Net Cash Flow From Investing Activities | $2.15M |
| Net Cash Flow From Investing Activities, Continuing | $2.15M |
| Net Cash Flow From Financing Activities | $9.86M |
| Net Cash Flow From Financing Activities, Continuing | $9.86M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$12.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.16M |
| Other Comprehensive Income/Loss | $0.00 |